Primary Effusion Lymphoma
specificA large B-cell lymphoma usually presenting as a serous effusion without detectable tumor masses. It is universally associated with human herpes virus 8 (HHV8), also called Kaposi sarcoma-associated herpesvirus. It mostly occurs in the setting of immunodeficiency. The most common sites of involvement are the pleural, pericardial, and peritoneal cavities. Rare HHV8-positive lymphomas indistinguishable from primary effusion lymphomas (PEL) present as solid tumor masses, and have been termed extrac
39
Centers
22
Active Trials
$42M
Cancer Funding
Top Centers for Primary Effusion Lymphoma(39)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive High-Volume Research Center | 78.1 |
| 2 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 66.5 |
| 3 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 66.3 |
| 4 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 66.3 |
| 5 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 55.9 |
| 6 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 55.0 |
| 7 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 54.8 |
| 8 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 54.8 |
| 9 | NCI Comprehensive Active Research Program | 54.8 |
| 10 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 54.8 |
| 11 | NCI Comprehensive Active Research Program | 54.8 |
| 12 | NCI Comprehensive Active Research Program | 54.8 |
| 13 | NCI Comprehensive Active Research Program | 54.8 |
| 14 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 54.8 |
| 15 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 54.8 |
| 16 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 54.8 |
| 17 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 54.8 |
| 18 | University of Illinois Cancer CenterChicago, IL Active Research Program | 54.8 |
| 19 | Boston University Cancer CenterBoston, MA Active Research Program | 54.8 |
| 20 | Cancer Center at IllinoisUrbana, IL Active Research Program | 54.8 |
| 21 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 54.8 |
| 22 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 54.8 |
| 23 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 54.1 |
| 24 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 53.2 |
| 25 | Active Research Program | 52.3 |
| 26 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 51.4 |
| 27 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 50.5 |
| 28 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 49.6 |
| 29 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 48.7 |
| 30 | NCI Comprehensive Active Research Program | 47.8 |
| 31 | NCI Comprehensive Active Research Program | 46.9 |
| 32 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 46.0 |
| 33 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 33.5 |
| 34 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 33.5 |
| 35 | NCI Comprehensive | 33.5 |
| 36 | NCI Comprehensive | 33.5 |
| 37 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 33.5 |
| 38 | NCI Clinical | 33.5 |
| 39 | Louisiana Cancer Research CenterNew Orleans, LA | 33.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →